Monitoring
The follow-up interval recommended for the following diabetic
retinopathy severity:
- 1 year in patients with no apparent diabetic retinopathy or minimal non-proliferative diabetic retinopathy and without DME
- 12 months for mild non-proliferative diabetic retinopathy without CSME
- 3-6 months if with DME
- 6-12 months for moderate non-proliferative diabetic retinopathy
- 3-6 months if with DME
- 3-4 months for severe non-proliferative diabetic retinopathy
- 2-4 months if with DME
- 3-4 months for non-high-risk proliferative diabetic retinopathy
- 2-4 months if with DME
- 2-4 months for non-high-risk proliferative diabetic retinopathy with or without DME
Recommended follow-up interval for patients with DME on initial
screening:
- 2-6 months for noncentral-involved DME
- 1-3 months for central-involved DME
Post-op Follow-up and Follow-up After Screening
A history of changes in symptoms, glycemic status (HbA1c), systemic status (eg pregnancy, blood pressure, serum
cholesterol, renal status), and other treatments (eg dialysis, fenofibrates) should
be documented. The follow-up exam should include visual acuity, slit-lamp
biomicroscopy with iris examination, IOP determination, gonioscopy (if iris
neovascularization is suspected or present or if IOP is increased),
stereoscopic examination of the posterior pole after dilation of the pupils,
OCT when necessary, and peripheral retina and vitreous examination, when
indicated.